Pipeline Development

Gilead Sciences, Inc. (GILD): Growth Outlook Supported by Analyst Updates

amefika3 months ago02 mins

Gilead Sciences Inc. (NASDAQ:BROWN) is one of Goldman Sachs’ top healthcare stocks. On March 10, Jefferies initiated coverage of Gilead Sciences Inc. (NASDAQ:GILD) with a Buy rating and a $180 price target. The research firm has touted the company’s earnings per share growth and margin expansion prospects as part of its bullish thesis. Gilead Sciences,…

Wall Street Bullish on BeOne Medicines AG (ONC) Amid Strong Pipeline Development

amefika4 months ago02 mins

BeOne Medicines AG (NASDAQ:ONC) is one of the best healthcare stocks to buy in 2026. On January 13, at the 44th Annual JP Morgan Healthcare Conference, BeOne Medicines AG (NASDAQ:ONC) reiterated significant progress in the development of its product portfolio. Wall Street Bullish on BeOne Medicines AG (ONC) Amid Strong Pipeline Development BRUKINSA, a tyrosine…